Understand the distinction between compounded tirzepatide and FDA-approved Mounjaro.
Mounjaro
Mounjaro is an FDA-approved tirzepatide product with specific labeling and indication.
Compounded product
Compounded tirzepatide is a separately prepared unapproved product under compounding laws.
Do not compare on price alone
The effective cost can be very different, but product status, clinical indication and coverage matter alongside cash price.
Sources & verification
We use primary sources for time-sensitive commercial and regulatory claims.
- FDA — Compounding and the FDA: Questions and Answers
- FDA — Concerns with unapproved GLP-1 drugs used for weight loss
Last reviewed: August 19, 2026